Preclinical studies have found that chronic hyperglycemic metabolic stress may induce the increased secretion of NLRP3-dependent IL-1β, possibly leading to the development of T2DM and that reducing the production of IL-1β may lessen the incidence of T2DM in animal models [44, 52]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.